ArticleFrontiers in oncology2025
Case Report: Popliteal arterial tumor embolus as the initial presentation of EGFR-mutant lung adenocarcinoma with pulmonary-vein invasion.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thrombotic events represent a common complication and the second leading cause of mortality among patients with non-small cell lung cancer (NSCLC). Nonetheless, it is exceedingly rare for thrombosis to manifest initially in atypical locations, such as the popliteal artery, in individuals with NSCLC. In this report, we present a case involving an elderly patient with NSCLC who initially exhibited acute thrombosis of the popliteal artery in the left limb. The patient underwent a salvage arterial thrombectomy followed by a transfemoral amputation. Pathological examination revealed that the thrombus was a tumor embolus. A chest CT scan identified a mass in the right lower lung with a maximum diameter of 2.8 cm, along with multiple pulmonary nodules and a clot in the right inferior pulmonary vein. Pathological analysis of the lung mass confirmed the presence of lung adenocarcinoma, thereby verifying that the tumor embolus originated from NSCLC. The patient subsequently received treatment with osimertinib, resulting in partial remission. In instances of thrombosis occurring in uncommon sites, it is crucial to consider the potential for tumor thrombus.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.